NCT00495352View on ClinicalTrials.gov

The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia

PHASE4CompletedINTERVENTIONAL

Enrollment

360

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

December 31, 2008

Conditions

Tobacco DependenceSchizophrenia

Interventions

DRUG

Hihg-doseNRT, Low-dose NRT, bupropion

Trial Locations (1)

981

Yuli hospital, DOH, Yuli Townhsip

All Listed Sponsors

collaborator

National Health Research Institutes, Taiwan

OTHER

collaborator

Department of Health, Executive Yuan, R.O.C. (Taiwan)

OTHER_GOV

lead

Yu-Li Hospital

OTHER

NCT00495352 - The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia | Biotech Hunter | Biotech Hunter